| How fat is distributed in people's bodies could make a difference to their risk of certain cancers, according to new research led by the University of Bristol. The international study is published in the Journal of the National Cancer Institute (JNCI) today [24 September]. | |
|
| In 2023, the groundbreaking Australian BANDIT (Baricitinib in New Onset Type 1 Diabetes) trial [1] reported that a daily pill of baricitinib, commonly prescribed for rheumatoid arthritis and alopecia, could safely preserve the body's own insulin production and slow the progression of type 1 diabetes (T1D) in people recently diagnosed with the condition. | |
|
| The Crohn's & Colitis Foundation and an international consortium of leading IBD researchers, today announced the launch of the Global IBD Registry (GLIDE), a pioneering initiative designed to securely connect data from inflammatory bowel disease (IBD) registries around the world. | |
|
| In a recent cross-sectional study, researchers from Pennington Biomedical Research Center found that severe obesity is associated with a lower rate of cancer screenings. | |
|
| Explore how 3D fluorescence microscopy is revealing the molecular mechanisms that drive cancer metastasis. | |
|
| Researchers tested blueberry powder as one of the first complementary foods in human milk-fed infants. The trial found exploratory evidence that blueberries may support healthier gut microbiota development during early life. | |
|
| Learn how the iconPCR can be used to achieve superior FFPE workflows. | |
|
| Enhance your NGS workflows using the iconPCR for improved data quality. | |
|
| Learn how scientists achieved higher biological resolution from metagenomic soil samples using the iconPCR. | |